Loading clinical trials...

Examining the Feasibility of Implementing a Hypertension Storytelling Intervention Among African Americans | Clinical Trials | Clareo Health

RECRUITINGNA

Examining the Feasibility of Implementing a Hypertension Storytelling Intervention Among African Americans

Examining the Feasibility of Implementing a Hypertension Storytelling Intervention Among African Americans With Hypertension

NCT07071077•University of Delaware

View on ClinicalTrials.gov

Summary

The purpose of this study is to assess if storytelling is an effective approach for promoting lifestyle and behavioral change among individuals managing hypertension and to determine if storytelling interventions can help to reduce blood pressure and improve medication adherence.

Eligibility

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•African American/Black
•Diagnosed with Hypertension
•Prescribed medication for hypertension

Exclusion Criteria

•Cognitive limitations that limit the ability to provide informed consent
•Pregnancy
•Unable to speak or read English
•Planning to relocate during the study period

Locations (1)

University of Delaware

Newark, Delaware, United States

Key Dates

Start Date

January 29, 2025

Primary Completion Date

May 31, 2026

Completion Date

May 31, 2026

Last Updated

July 17, 2025

Enrollment

ESTIMATED participants

Conditions

Hypertension

Interventions

Web-Based Storytelling Intervention

BEHAVIORAL

Group-Based Storytelling Plus Intervention

BEHAVIORAL

Natural History of Noncirrhotic Portal Hypertension

NCT02417740

Cystic FibrosisImmunologic Deficiency Syndrome+3 more

View study

RECRUITING

Homocysteine and Early Diastolic Dysfunction in Newly Diagnosed Hypertension

NCT07480265

Hypertension (HTN)Hyperhomocysteinemia+1 more

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: July 17, 2025Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Examining the Feasibility of Implementing a Hypertension Storytelling Intervention Among African Americans

Inclusion Criteria

Exclusion Criteria

Natural History of Noncirrhotic Portal Hypertension

Homocysteine and Early Diastolic Dysfunction in Newly Diagnosed Hypertension

A Study to Learn About the Study Medicine (Called PF-07868489) in People With Pulmonary Arterial Hypertension Who Have Previously Participated in a Clinical Study With PF-07868489

Mobile Cued Adherence Therapy (mCAT) for Blood Pressure Medication

Penn Medicine Healthy Heart

Preliminary Human Trials of F230 Tablets